Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Claritas Pharmaceuticals Inc
CLAZF
Healthcare
Biotechnology
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID...
viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:CLAZF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(86)
•••
GreatGabbo
X
View Profile
View Bullboard History
Post by
GreatGabbo
on Sep 08, 2022 8:32am
Bob where are you!
The investors would like their money back Bobby!!!
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 06, 2022 9:32pm
RE:RE:Nitric Oxide video
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 06, 2022 9:14pm
RE:Nitric Oxide video
Available to 22% of the world but not approved in Canada
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 06, 2022 8:13pm
Nitric Oxide video
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 05, 2022 4:02pm
Nitric Oxide Market Size
Inhaled Nitric Oxide Market Size is projected to reach USD 1.54 Billion by 2030
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 05, 2022 3:54pm
Bellerophon Provides Clinical Program Update
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 04, 2022 7:22pm
nitric oxide synthase
Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease The homeostatic production of nitric oxide synthases (NOS) becomes
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 03, 2022 7:06pm
BeyondAir
Unlimited, on-demand generation of nitric oxide from room air, regardless of dose or flow. No cylinders, no hassle.1 https://lungfitph.com/
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 03, 2022 6:58pm
N.O. in the news
Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov) Jedidiah
...more
(28)
•••
PTBailey
X
View Profile
View Bullboard History
Comment by
PTBailey
on Sep 02, 2022 10:38pm
RE:RE: RE:Top gun...lighten up, eh
Be a man call me.
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 02, 2022 9:30pm
RE: RE:Top gun...lighten up, eh
Where's a good paid pumper when you need one?
(28)
•••
PTBailey
X
View Profile
View Bullboard History
Comment by
PTBailey
on Sep 02, 2022 9:07pm
RE: RE:Top gun...lighten up, eh
You really need to come up with something new, this is getting boring.
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 02, 2022 8:21pm
RE:Top gun...lighten up, eh
The previous post may contain certain forward-looking information and statements that are not based on historical fact, including without limitation in respect of its product candidate pipeline,
...more
(28)
•••
PTBailey
X
View Profile
View Bullboard History
Comment by
PTBailey
on Sep 02, 2022 12:37am
RE:Top gun Drew
Not sure why he needs to explain anything. I do find it interesting that when things looked good many were interested in his opinion and now that things don't look so good he is a villian. Yet if
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 01, 2022 9:25pm
BTW CLAS
If you 2 or 3 need to talk to Drew, there is a better way to reach him than continuously posting here.....since he hasn't been here for a while and never was a regular here .....not sure why you
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.